Civi Biopharma, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Chevy Chase MD United States (2016)

Organization Overview

First Clinical Trial
2018
NCT03427710
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

CiVi Biopharma | Civibio Pharma, Inc. | Civi Biopharma, Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

iloprost (ventavis) (2 trials)

Drugs in Phase 2 Trials (1)

civi 007 (1 trial)

Drugs in Phase 1 Trials (1)

civi007 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 2)

Neoplasm Metastasis (Phase 3)

Raynaud Disease (Phase 3)

Scleroderma, Diffuse (Phase 3)

Scleroderma, Systemic (Phase 3)

Sclerosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3